Viruses on the Brain

Viral infections of the central nervous system may trigger cytokines that induce seizures.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

DISSECTING SEIZURES: Mice that suffer seizures after viral infection have a greater number of macrophages (green) in the brain.COURTESY OF ROBERT FUJINAMThe paper
M.F. Cusick et al., “Infiltrating macrophages are key to the development of seizures following virus infection,” J Virol, 87:1849-60, 2013.

The matter
Of the approximately 2.2 million Americans affected by epilepsy, a third do not respond to current antiseizure treatments, and nearly three quarters of all cases have unknown causes. Though scientists have previously linked more than 100 species of viruses that infect the central nervous system (CNS) to patients suffering from recurring seizures, the significance of viral infections in epilepsy is still unclear.

The model
Researchers at the University of Utah School of Medicine, led by Robert Fujinami, had previously developed a mouse model that suffered from seizures after infection with a CNS-targeting virus. Though the mice could clear the infection, they often continued to have seizures. To dissect how the virus might spark recurring seizures during and long after infection, Fujinami and his team took a close look at the immune responses.

The match
Fujinami’s team found that during a viral brain infection, infiltrating macrophages produce high levels of a cytokine called interleukin 6 (IL-6), which, among other cytokines, had previously been linked to seizures in the mice. To understand the importance of these IL-6–spewing macrophages, the team used a drug to block them from the CNS, which resulted in the mice having fewer seizures. Though it’s still unclear how the virus triggers seizures after the infection, Fujinami and his team suspect that macrophages continue to swarm the CNS.

The aftermath
The results suggest that “the side effect of this powerful immune response is a disruption in brain function and the ensuing brain seizures,” says Thomas M. Petro of the University of Nebraska Medical Center, who was not involved in the study.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies